H. Hörig

发表

In vivo CTL immunity can be elicited by in vitro reconstituted MHC/peptide complex.

I. Sakita, S. Nathenson, F. Wang, 1996, Journal of immunological methods.

Poxviruses as vectors for cancer immunotherapy.

H. Kaufman, Heesun Kwak, H. Hörig, 2003, Current opinion in drug discovery & development.

Prostate-specific antigen vaccines for prostate cancer

H. Kaufman, Christopher S D Lee, H. Hörig, 2002, Expert opinion on biological therapy.

Current issues in cancer vaccine development.

H. Kaufman, H. Hörig, 1999, Clinical immunology.

The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells.

H. Kaufman, K. Flanagan, D. Moroziewicz, 2004, Cellular immunology.

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

J. Schlom, H. Kaufman, J. Tine, 2000, Cancer Immunology, Immunotherapy.

Combination interleukin-2 and interleukin-12 induces severe gastrointestinal toxicity and epithelial cell apoptosis in mice.

I. Lubensky, H. Kaufman, H. Hörig, 2002, Cytokine.

A new mouse model for evaluating the immunotherapy of human colorectal cancer.

R. Kucherlapati, H. Kaufman, W. Edelmann, 2001, Cancer research.

A phase I trial of intra lesional RV-B7.1 vaccine in the treatment of malignant melanoma.

T. Ravikumar, S. Mani, H. Kaufman, 2000, Human gene therapy.

Nitric oxide-independent inhibitory effects of L-arginine analog NG-monomethy-L-arginine on the generation of interleukin-2 activated cytotoxic activity in humans.

M. Heberer, F. Harder, A. Juretić, 1996, Clinical nutrition.

Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.

Wancai Yang, H. Kaufman, K. Flanagan, 2004, Vaccine.

Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes

R. Furneaux, V. Schramm, P. Tyler, 2001, Proceedings of the National Academy of Sciences of the United States of America.

The RAGE axis in early diabetic retinopathy.

A. Schmidt, T. Wendt, G. Barile, 2005, Investigative ophthalmology & visual science.

From bench to clinic and back: Perspective on the 1st IQPC Translational Research conference

W. Pullman, Heidi Hörig, William Pullman, 2004, Journal of Translational Medicine.

Exogenous glutamine requirement is confined to late events of T cell activation

L. Filgueira, M. Heberer, A. Juretić, 1993, Journal of cellular biochemistry.

Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area.

N. Papadopoulos, S. Nathenson, A. Kalergis, 1998, Molecular immunology.

On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity.

P. Dellabona, L. Filgueira, M. Zuber, 1993, Cellular immunology.

Glutamine peptide-supplemented long-term total parenteral nutrition: effects on intracellular and extracellular amino acid patterns, nitrogen economy, and tissue morphology in growing rats.

F. Gudat, P. Stehle, M. Oberholzer, 1993, JPEN. Journal of parenteral and enteral nutrition.

Innovative treatments for pancreatic cancer.

H. Kaufman, S. Lieberman, H. Hörig, 2001, The Surgical clinics of North America.

Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma.

F. Marincola, E. Wang, H. Kaufman, 2005, The Journal of clinical investigation.

Local delivery of poxvirus vaccines for melanoma.

H. Kaufman, H. Hörig, 2003, Seminars in cancer biology.

Immunotherapy for pancreatic cancer: current concepts.

H. Kaufman, H. Hörig, J. Di Vito, 2002, Hematology/oncology clinics of North America.

An in vitro study of the dynamic features of the major histocompatibility complex class I complex relevant to its role as a versatile peptide-receptive molecule.

R. Angeletti, N. Papadopoulos, S. Nathenson, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Strategies for cancer therapy using carcinoembryonic antigen vaccines

F. Medina, H. Kaufman, H Hörig, 2000, Expert Reviews in Molecular Medicine.

Obstacles and opportunities in translational research

F. Marincola, Heidi Hörig, Elizabeth Marincola, 2005, Nature Medicine.

A phase I trial of intralesional rV-Tricom vaccine in the treatment of malignant melanoma.

H. Kaufman, D. Lee, G. Deraffele, 2001, Human gene therapy.

Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.

N. Papadopoulos, N. Papadopoulos, S. Nathenson, 1999, Journal of immunology.

Criteria of the Inherent MHC Class I Peptide Binding Extended at Their C Terminus : Refinement Heterodimer Is Restricted to Peptides bBinding of Longer Peptides to the H-2 K

T. DiLorenzo, Papadopoulos, H. Hörig, 1999 .

Glutamine requirements in the generation of lymphokine-activated killer cells.

M. Heberer, F. Harder, A. Juretić, 1994, Clinical nutrition.

Role of glutamine in the immune response in critical illness.

M. Heberer, F. Harder, A. Juretić, 1996, Nutrition.

Tyrosine kinase-dependent and -independent events induced by interleukin-2 stimulation: interleukin-2-mediated NO production required for the induction of lymphokine-activated killer cell activity in rat splenocytes is tyrosine kinase independent.

R. Shipman, T. Kocher, M. Heberer, 1995, Immunology.

Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA.

E. Eppler, H. Kaufman, L. Filgueira, 2002, European journal of cancer.

Generation of lymphokine-activated killer activity in rodents but not in humans is nitric oxide dependent.

L. Filgueira, M. Heberer, F. Harder, 1994, Cellular immunology.